Amarin Corp PLC (AMRN)

3.03
0.01 0.33
NASDAQ : Health Care
Prev Close 3.04
Open 3.05
Day Low/High 3.00 / 3.06
52 Wk Low/High 1.24 / 2.59
Volume 1.00M
Avg Volume 2.56M
Exchange NASDAQ
Shares Outstanding 270.79M
Market Cap 823.21M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week Of July 21st Options Trading For Amarin (AMRN)

Investors in Amarin Corp plc saw new options begin trading this week, for the July 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 87 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Biotech Premarket Movers: Cempra, Novavax, Ionis

Biotech Premarket Movers: Cempra, Novavax, Ionis

Cempra, Novavax and Ionis Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.

Interesting AMRN Call Options For May 19th

Investors in Amarin Corp plc saw new options begin trading this week, for the May 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 86 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Pure EPA Vascepa® Now Available In New, Smaller Half-Gram Capsule Size

Pure EPA Vascepa® Now Available In New, Smaller Half-Gram Capsule Size

Amarin Expands Vascepa Franchise with First-and-Only 0.5-gram Prescription Omega-3 Option for Healthcare Providers Treating Patients Who Prefer a Smaller Capsule

Amarin Randomizes Final Patient Into REDUCE-IT Cardiovascular Outcomes Study Of Vascepa

Amarin Randomizes Final Patient Into REDUCE-IT Cardiovascular Outcomes Study Of Vascepa

8,175 Individual Patients Randomized and All Global Sites Closed to Enrollment

Amarin (AMRN) Stock Drops After Pricing Public Offering

Amarin (AMRN) Stock Drops After Pricing Public Offering

Amarin (AMRN) stock was declining after pricing its public offering at a discount.